Official and authoritative background links used for intake education.
Zantac lawsuit evidence checklist and intake guidance
Zantac reviews focus on ranitidine use history, dosage, duration, and diagnosis records for cancers that have been associated with NDMA contamination in ranitidine-based medications.
A Zantac lawsuit is a legal claim filed by people who developed cancer after taking Zantac and ranitidine tainted with NDMA. Zantac lawsuits seek compensation from the drug makers for cancers of the bladder, stomach, esophagus, liver, and pancreas that may have been caused by NDMA exposure.

Bladder, gastric/stomach, esophageal, liver and pancreatic
Sanofi-Aventis U.S. LLC, Sanofi US Services Inc., Chattem, Inc., Boehringer Ingelheim, Pfizer and GlaxoSmithKline
Initial stages, no trials scheduled
- Bladder
- Gastric/Stomach
- Esophageal
- Liver
- Pancreatic
People must meet several prerequisites, according to Zantac lawyers, in order to be eligible for a lawsuit: documented Zantac use, a cancer diagnosis, and a link between the disease and Zantac. Lawyers are only considering claims from persons who used the brand-name Zantac, and generic ranitidine is no longer covered.
Only a lawyer can correctly evaluate a claim, as well as assist in the collection of medical documents and data needed to develop a case.
Free Case Review
According to Zantac lawyers, several doctors who diagnosed persons with cancer after taking Zantac indicated they had no family history or genetic indications for cancer. Instead, doctors told patients that the illness was due to something in their surroundings, such as NDMA poisoning.
Case Review Form
Campaign guidance, records, and sources
Review the supporting information below before or after completing the private campaign form.
A practical checklist to help organize useful details before review.
Reviewed for intake accuracy by AMMS Compliance Team
Records and details that may help
- Pharmacy records, prescription history, or purchase receipts showing Zantac or ranitidine use
- Approximate years of use, dosage, and whether use was prescription or over-the-counter
- Diagnosis records for bladder, stomach, esophageal, colorectal, or other associated cancers
- Prior claim or attorney inquiry information if applicable
Sources used for intake education
These official references are provided for background education only. They do not replace medical or legal advice.
- FDA Zantac recall announcementOfficial FDA recall and safety communications about NDMA contamination in ranitidine products.
1. Submit the intake form
Share your contact details and answer the existing campaign-specific questions.
2. Organize supporting details
Gather the records, dates, communications, and other details listed for this campaign.
3. Intake follow-up
AMMS or an authorized intake partner may contact you for missing or clarifying details.
4. Legal review if appropriate
Qualified legal professionals decide whether a claim can move forward. AMMS does not provide legal advice or guarantee results.
Frequently asked questions
What Zantac use information is most helpful for intake?
How long you took Zantac, the dosage, whether it was prescribed or purchased over-the-counter, and pharmacy records or prescription history are useful for intake review.
Can I submit a Zantac review without a cancer diagnosis?
Intake reviews typically focus on individuals with a relevant diagnosis. If you have questions about eligibility, you can describe your situation when you submit.


